Univariate and multiple factor analysis of TIM-3/TIGIT or TIM-3/2B4 co-expression on peripheral CD8+ T cells and progression-free survival in 83 patients with nasopharyngeal carcinoma. This evidence concerns the gene CD8A and nasopharyngeal carcinoma.